Skip to content
naulon

Not checkedNot checked for notices yet.

Aberrant sialylation in a patient with a HNF1α variant and liver adenomatosis

Luisa Sturiale, Marie-Cécile Nassogne, Angelo Palmigiano and 11 more

iScience · 2021

doi:10.1016/j.isci.2021.102323 (opens in a new tab)

We email you when a new notice or a question about this paper appears.

Abstract

Summary: Glycosylation is a fundamental post-translational modification of proteins that boosts their structural diversity providing subtle and specialized biological properties and functions. All those genetic diseases due to a defective glycan biosynthesis and attachment to the nascent glycoproteins fall within the wide area of congenital disorders of glycosylation (CDG), mostly causing multisystem involvement. In the present paper, we detailed the unique serum N-glycosylation of a CDG-candidate patient with an unexplained neurological phenotype and liver adenomatosis harboring a recurrent pathogenic HNF1α variant. Serum transferrin isoelectric focusing showed a surprising N-glycosylation pattern consisting on hyposialylation, as well as remarkable hypersialylation. Mass spectrometry-based glycomic analyses of individual serum glycoproteins enabled to unveil hypersialylated complex N-glycans comprising up to two sialic acids per antenna. Further advanced MS analysis showed the additional sialic acid is bonded through an α2-6 linkage to the peripheral N-acetylglucosamine residue.

Abstract licence: CC BY-NC-ND

References66

  1. 20.
  2. 32.

38 more references, whose wording the paper’s licence keeps private.

All 66 references

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.